The Ohio State University Dermatology Biorepository
Part of paid clinical trials in Columbus, Ohio.
- Sponsor
- Ohio State University
- Study ID
- NCT03146676
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Accepted
Study Details
This study will create and extend a source of clinical specimens for the future study of inflammatory skin disorders.
Key Dates
- Start date
- Apr 19, 2017
- Status verified
- Feb 2026
- Primary completion
- Dec 31, 2030
- Completion
- Dec 31, 2030
Study Design
- Enrollment
- 175 participants (estimated)
Primary Outcome Measure
Source of clinical specimens for the future study of neoplastic and inflammatory skin disorders [ Time Frame: 5 years ]
Central Contacts
- Alison Rocchi614-685-0251
- Kristina Susi614-814-1277
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| OSU Dermatology West | Columbus | Ohio | 43215 | Benjamin Kaffenberger, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Columbus, OH
By condition
By specialty
By research site
Related Studies
- Myriad™ Augmented Soft Tissue Reconstruction RegistryRecruiting · Aroa Biosurgery Limited · Los Angeles, California
- A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF TherapyPHASE3 · Recruiting · AbbVie · Birmingham, Alabama
- A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis SuppurativaPHASE3 · Recruiting · UCB Biopharma SRL · Phoenix, Arizona
- Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2)PHASE3 · Recruiting · Incyte Corporation · Birmingham, Alabama